Alerts will be sent to your verified email
Verify EmailISTRNETWK
|
iStreet Network
|
Medicamen Biotech
|
Valiant Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.48 % | 6.92 % | 9.66 % |
|
5yr average Equity Multiplier
|
-1.13 | 1.44 | 1.76 |
|
5yr Average Asset Turnover Ratio
|
0.21 | 0.55 | 0.81 |
|
5yr Avg Net Profit Margin
|
1.44 % | 8.69 % | 2.4 % |
|
Price to Book
|
7.73 | 1.26 | 1.15 |
|
P/E
|
71.38 | 36.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
22.21 Days | 49.75 Days | 75.62 Days |
|
Inventory Days
|
0.0 | 84.58 Days | 18.84 Days |
|
Days Receivable
|
220.87 Days | 139.4 Days | 161.25 Days |
|
Days Payable
|
39.73 Days | 264.75 Days | 82.33 Days |
|
5yr Average Interest Coverage Ratio
|
-107.0 | 7.03 | 44.93 |
|
5yr Avg ROCE
|
-79.54 % | 10.34 % | 7.68 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | 15.51 % | 0.79 % |
|
5 yr average Debt to Equity
|
-1.09 | 0.15 | 0.48 |
|
5yr CAGR Net Profit
|
n/a | -11.57 % | n/a |
|
5yr Average Return on Assets
|
-113.8 % | 4.73 % | 4.39 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
19.33 % | 40.46 % | 74.94 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-26.87 % | -2.75 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
iStreet Network
|
Medicamen Biotech
|
Valiant Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|